EnviroTech :: Regulatory
U.S. Patent Reform ‘Disappoints’ BIO
10:54 AM MDT | September 21, 2007 | Chemical Week Editorial Staff
Biotech industry association BIO (Washington) says it is “disappointed” by the Patent Reform Act that the U.S. House of Representatives recently passed (p. 49). BIO cannot support the act, says BIO president and CEO Jim Greenwood. The bill, which the Senate has not yet voted on, “threatens continued biotechnological innovation,” the association says. BIO says it is particularly concerned that the act would extend the opportunity to challenge a patent, diminishing its value and reducing incentives for...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee